CAS: 170981-26-7; (2-Fluoro-4-Methylphenyl)Boronic Acid

该化合物是一种有机体化合物,其特点是,一个附于一个苯环上的碱酸功能组,该组同时被氟原子和甲基组所取代,该化合物一般是白色的,是白色的,是非白色的固体,在极地有机溶剂中可溶解,其分子结构特征是,一个碳原子与一个氢氧基组和一个丙烯组结合,这增强了其在各种化学反应中的再活动性,特别是在铃木组合反应中,使其在有机合成和药用化学中具有价值.

结构式图片

相似化合物

1165936-03-7 871126-22-6 1150114-77-4

欧盟法规

C&L通报

上下游产品

CAS号452-74-4 3-氟-4-溴甲苯 | CAS号669770-60-9 3-氯-6-(2-氟-4-甲基...

合成工艺路线路线简述

    4-溴-3-氟甲苯置于正丁基锂,硼酸三异丙酯体系中,用 四氢呋喃,正己烷,甲苯 用作溶剂,化学反应 2.0H,反应生成2-氟-4-甲基苯硼酸
    参考文献: Aza-Bicycloalkyl Ethers And Their Use As Alpha7-Nachr Agonist[fr] Ethers D'Aza-Bicycloalkyle Et Leur Utilisation En Tant Qu'Agoniste De Alpha7-Nachr
    标题: Aza-Bicycloalkyl Ethers And Their Use As Alpha7-Nachr Agonist[fr] Ethers D'Aza-Bicycloalkyle Et Leur Utilisation En Tant Qu'Agoniste De Alpha7-Nachr
    摘要:本发明涉及式(I)的1-Aza-双环烷基衍生物,其中x是ch2或单键;Y是式(Ii,Iii,Iv)的一个基团,其中r的含义如规范中定义的那样,这些化合物是α7烟碱型乙酰胆碱受体(Nachr)激动剂;以及它们的生产过程,作为药物的使用以及包含它们的药物组合物.

    海关参考信息

    专利信息


    专利号:US-2025304580-A1
    优先权日:2021-11-09
    标 题:Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
    发明人:HOUZE JONATHAN B; PANDYA BHAUMIK; KAPLAN ALAN P; BOS MAXENCE; MANCUSO JOHN; FRANZONI IVAN
    权利人:VIGIL NEUROSCIENCE INC
    摘要:The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 (“TREM2â€?).This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula I.

    专利号:WO-2024233848-A1
    优先权日:2023-05-10
    标 题:Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
    发明人:HOUZE JONATHAN B; PANDYA BHAUMIK
    权利人:VIGIL NEUROSCIENCE INC
    摘要:The present disclosure provides compounds useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 ('TREM2'). This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (I).

    专利号:US-12319691-B2
    优先权日:2020-05-04
    标题 :Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
    发明人:CZABANIUK LARA C; HOPPER TIMOTHY; HOUZE JONATHAN B; RESCOURIO GWENAELLA; SANTORA VINCENT; WANG HAOXUAN; WHITE RYAN D; WONG ALICE R; WU YONGWEI
    权利人:AMGEN INC; VIGIL NEUROSCIENCE INC
    摘要:The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 (“TREM2â€?).This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula I.

    专利号:US-12428425-B2
    优先权日:2020-05-04
    标 题:Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
    发明人:CZABANIUK LARA C; HOPPER TIMOTHY; HOUZE JONATHAN B; PANTELEEV JANE; RESCOURIO GWENAELLA; SANTORA VINCENT; WANG HAOXUAN; WHITE RYAN D; WONG ALICE R; WU YONGWEI; BOS MAXENCE; MANCUSO JOHN; FRANZONI IVAN
    权利人:AMGEN INC; VIGIL NEUROSCIENCE INC
    摘要:The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 (“TREM2â€?).This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula I.

    专利号:US-9040704-B2
    优先权日:2011-08-12
    标题:Fluorescent dyes with large stokes shifts
    发明人:PIERS WARREN EDWARD; ARANEDA JUAN FELIPE
    权利人:PIERS WARREN EDWARD; ARANEDA JUAN FELIPE; UTI LIMITED PARTNERSHIP
    摘要:Herein are disclosed fluorescent dyes based around a framework for a ligand comprising a pyridyl group linked to a diaryl anilido unit. A variety of ligands based on this framework are disclosed. The ligands chelate to a BF 2 center to produce the fluorescent dye. The disclosed dyes combine longer Stokes shifts (approximately 100 nm) with increased quantum yields. They are also photostable in aqueous and organic solutions for several hours. These dyes may be used in the labeling of biomolecules for bioimaging and assays. Also disclosed are methods for the synthesis of these dyes.

    专利号:US-8933018-B2
    优先权日:2011-02-07
    标题 :Boron containing polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
    发明人:GLINKA TOMASZ; HIGUCHI ROBERT; HECKER SCOTT; EASTMAN BRIAN; RODNY OLGA
    权利人:GLINKA TOMASZ; HIGUCHI ROBERT; HECKER SCOTT; EASTMAN BRIAN; RODNY OLGA; REMPEX PHARMACEUTICALS INC
    摘要:Disclosed herein are polybasic bacterial efflux pump inhibitors containing boronic acid functionality and their methods of synthesis, methods of use, and pharmaceutical compositions. Some embodiments include methods of treating or preventing a bacterial infection by co-administering to a subject infected with bacteria or at risk of infection with bacteria the efflux pump inhibitor with another anti-bacterial agent.
    北京普瑞东方化学技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bjpurechem.com
    企业联系电话:010-83993285👤
    📞北京普瑞东方化学技术有限公司 ⚠️参考联系方式
    联系人:冷先生
    电话:010-83993285
    手机:17610176018
    传真:010-63370219
    邮箱:sales@bjpurechem.com
    通信地址: 北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
    邮编: 100048
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北襄西化学工业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xiangxibio.com
    电话: 0086-710-3454830👤
    📞湖北襄西化学工业有限公司 ⚠️参考联系方式

    销售电话:0086-710-3454830
    邮箱:xiangxi@xiangxibio.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Mordini, A.; Valacchi, M., Science of Synthesis, (2006) 8, 1468.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知